Bloomberg | Leading Cancer Center No Longer Offering Zantac to Patients

Bloomberg published an article titled, "Leading Cancer Center No Longer Offering Zantac to Patients." The article highlights Valisure's detections of NDMA in Zantac pills and its generics.

View the article via Bloomberg here.

Bloomberg | Leading Cancer Center No Longer Offering Zantac to Patients

October 2, 2019

Bloomberg published an article titled, "Leading Cancer Center No Longer Offering Zantac to Patients." The article highlights Valisure's detections of NDMA in Zantac pills and its generics.

View the article via Bloomberg here.

Bloomberg | Leading Cancer Center No Longer Offering Zantac to Patients

Bloomberg published an article titled, "Leading Cancer Center No Longer Offering Zantac to Patients." The article highlights Valisure's detections of NDMA in Zantac pills and its generics.

View the article via Bloomberg here.

Bloomberg published an article titled, "Leading Cancer Center No Longer Offering Zantac to Patients." The article highlights Valisure's detections of NDMA in Zantac pills and its generics.

View the article via Bloomberg here.

SIGN UP FOR THE VALISURE NEWSLETTER 

Sign up to stay updated with Valisure announcements, relevant industry news, company updates, and more. 

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.